Husky Technologies recently celebrated the expansion of its facilities in India with ceremonies at its new offices and existing Chennai campus. The events were hosted by local leaders in the region, as well as senior executive Robert Domodossola, president of Husky’s Rigid Packaging business.

“This celebration reaffirms our commitment to the strong relationships we’ve been building with our customers in this region since 1999. As we enter our 70th year in business, this investment truly acknowledges the opportunities for growth and demand for Husky’s diverse range of complete solution offerings in India,” said Domodossola.

At the ceremony, the maker of plastics processing equipment headquartered in Bolton, ON, announced a number of initiatives for India that will be executed throughout 2023. They include:

Local production of blood collection tubes aligns with the goals of India’s National Medical Device Policy 2023, which was notified earlier this month. Among other objectives, it seeks to “place the Indian medical devices sector on an accelerated growth path . . . by building an innovative and globally competitive industry in India,” reports Lexology. Between 80 and 85% of medical devices currently sold in India are imported, according to various media outlets. The new policy aims to “reduce India’s import dependence to nearly 30% in the next couple of years, and become one of the top five global manufacturing hubs,” writes The Hindu BusinessLine.

Since selling its first PET system into India in 1999, Husky said its presence has grown to include more than 250 systems running in the field, delivery of more than 500 hot runners per year, and a team of trained service technicians and robust parts inventory to support local customers.